Diabetes medications remain leading drug category for eligible claims in 2023: report
In 2023, diabetes medications remained the leading drug category for eligible private insurance claims for the second consecutive year, according to Telus Health’s annual drug…
- By: Staff
- April 24, 2024 April 23, 2024
- 09:00












